These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36522705)

  • 1. Comparison between intravitreal ranibizumab injection and posterior subtenon triamcinolone acetonide injection at time of cataract surgery for prevention of progression of diabetic macular edema.
    Khalil MMAA; Mansour HO; Tawfik AMR; Elmahdy AG
    BMC Ophthalmol; 2022 Dec; 22(1):492. PubMed ID: 36522705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
    Choi YJ; Oh IK; Oh JR; Huh K
    Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results.
    Lim LL; Morrison JL; Constantinou M; Rogers S; Sandhu SS; Wickremasinghe SS; Kawasaki R; Al-Qureshi S
    Clin Exp Ophthalmol; 2016 May; 44(4):233-42. PubMed ID: 26871700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edema.
    Jeon SH; Kim M; Roh YJ
    BMC Ophthalmol; 2024 Jan; 24(1):25. PubMed ID: 38243166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Intravitreal Dexamethasone Implant and Posterior Subtenon Triamcinolone Injection in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes.
    Gumus G; Erdogan G; Gunay BO; Karatas Durusoy G
    Ophthalmologica; 2022; 245(5):439-445. PubMed ID: 35921811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suprachoroidal triamcinolone versus posterior subtenon triamcinolone either alone or formulated in the management of diabetic macular edema.
    Tharwat E; Ahmed REH; Eltantawy B; Ezzeldin ER; Elgazzar AF
    Int Ophthalmol; 2023 Dec; 43(12):4563-4571. PubMed ID: 37698662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
    Bressler SB; Qin H; Melia M; Bressler NM; Beck RW; Chan CK; Grover S; Miller DG;
    JAMA Ophthalmol; 2013 Aug; 131(8):1033-40. PubMed ID: 23807371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
    Kim MW; Moon H; Yang SJ; Joe SG
    Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the effect of intravitreal triamcinolone-moxifloxacin during cataract surgery on central macular edema in patients with preexisting diabetic retinopathy.
    Angkadjaja J; Chu J; Sierpina DI; Peng J; Rauser M
    J Cataract Refract Surg; 2020 Sep; 46(9):1253-1259. PubMed ID: 32384419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept.
    Ohara H; Harada Y; Hiyama T; Sadahide A; Minamoto A; Kiuchi Y
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374329
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the Efficacy of Sub-Tenon versus Intravitreal Triamcinolone Acetonide Injection during Cataract Surgery for Diabetic Macular Edema.
    Tatsumi T; Oshitari T; Ando T; Takatsuna Y; Arai M; Baba T; Sato E; Yamamoto S
    Ophthalmologica; 2019; 241(1):17-23. PubMed ID: 30041252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of macular edema after cataract surgery in diabetic patients, topical Nepafenac versus intravitreal Ranibizumab.
    Howaidy A; Eldaly ZH; Anis M; Othman TM
    Eur J Ophthalmol; 2022 Jan; 32(1):205-212. PubMed ID: 33726537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Combined with Posterior Subtenon Triamcinolone Acetonide in Diabetic Macular Edema.
    Karatas G; Erden B; Cakir A; Bolukbasi S; Erdenoz S; Argon BD; Elcioglu MN
    Beyoglu Eye J; 2021; 6(3):229-235. PubMed ID: 35005521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life experience of ranibizumab for diabetic macular edema in Taiwan.
    Tsai MJ; Hsieh YT; Peng YJ
    Int Ophthalmol; 2019 Jul; 39(7):1511-1522. PubMed ID: 29926364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
    ; Elman MJ; Aiello LP; Beck RW; Bressler NM; Bressler SB; Edwards AR; Ferris FL; Friedman SM; Glassman AR; Miller KM; Scott IU; Stockdale CR; Sun JK
    Ophthalmology; 2010 Jun; 117(6):1064-1077.e35. PubMed ID: 20427088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis.
    Qi HP; Bi S; Wei SQ; Cui H; Zhao JB
    Curr Eye Res; 2012 Dec; 37(12):1136-47. PubMed ID: 22793880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
    Yu SY; Nam DH; Lee DY
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):39-47. PubMed ID: 29030692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.